✦ LIBER ✦

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients

✍ Scribed by George P. Christophi; Jennifer A. Christophi; Ross C. Gruber; Cornelia Mihai; Luis J. Mejico; Paul T. Massa; Burk Jubelt

Book ID: 119304117
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 173 KB
Volume: 307
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2011.05.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of IFNβ-1a (Avonex®) and myc

Combination of IFNβ-1a (Avonex®) and mycophenolate mofetil (Cellcept®) in multiple sclerosis

✍ P. Vermersch; N. Waucquier; E. Michelin; H. Bourteel; T. Stojkovic; D. Ferriby; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

Interferon β1a (Avonex®) treatment in mu

Interferon β1a (Avonex®) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability

✍ Vermersch, P.; de Seze, J.; Stojkovic, T.; Hautecoeur, P. 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 269 KB

Synergistic immunomodulatory effects of

Synergistic immunomodulatory effects of interferon-β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis

✍ Frank Weber; Thomas Polak; Astrid Günther; Boris Kubuschok; Julia Janovskaja; An 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

The IgG subclass-specificities of anti-I

The IgG subclass-specificities of anti-IFNβ antibodies change with time and differ between the IFNβ products in relapsing remitting multiple sclerosis patients

✍ Ebrima Gibbs; Joel Oger 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 277 KB

fMRI changes in relapsing-remitting mult

fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNβ-1a injection

✍ Maria A. Rocca; Federica Agosta; Bruno Colombo; Domenico M. Mezzapesa; Andrea Fa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

## Abstract If fatigue in multiple sclerosis (MS) is related to an abnormal activation of the sensorimotor brain network, the activity of such a network should vary with varying fatigue. We studied 22 patients treated with interferon beta 1a (IFNβ‐1a; Avonex, Biogen, Cambridge, MA) with no fatigue

Complex immunomodulatory effects of inte

Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes

✍ Klaus-Peter Wandinger; Claus-Steffen Stürzebecher; Bibiana Bielekova; Greg Detor 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 753 KB